139 related articles for article (PubMed ID: 27266802)
1. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.
Cid S; Eiro N; González LO; Beridze N; Vazquez J; Vizoso FJ
Clin Breast Cancer; 2016 Aug; 16(4):e83-91. PubMed ID: 27266802
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Cid S; Eiro N; Fernández B; Sánchez R; Andicoechea A; Fernández-Muñiz PI; González LO; Vizoso FJ
Clin Breast Cancer; 2018 Feb; 18(1):e123-e133. PubMed ID: 28927692
[TBL] [Abstract][Full Text] [Related]
5. Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.
Fernández-Guinea O; Álvarez-Cofiño A; Eiró N; González LO; del Casar JM; Fernandez-Garcia B; Lamelas ML; Andicoechea A; Vizoso FJ
Int J Clin Oncol; 2013 Aug; 18(4):629-40. PubMed ID: 22688161
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
7. Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.
Cuadriello EF; Fernández-Guinea Ó; Eiró N; González LO; Junquera S; Vizoso FJ
Magn Reson Imaging; 2016 Oct; 34(8):1107-13. PubMed ID: 27114340
[TBL] [Abstract][Full Text] [Related]
8. Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
Del Casar JM; González-Reyes S; González LO; González JM; Junquera S; Bongera M; García MF; Andicoechea A; Serra C; Vizoso FJ
J Cancer Res Clin Oncol; 2010 Jun; 136(6):811-9. PubMed ID: 19916023
[TBL] [Abstract][Full Text] [Related]
9. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F
Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
García MF; González-Reyes S; González LO; Junquera S; Berdize N; Del Casar JM; Medina M; Vizoso FJ
Int J Exp Pathol; 2010 Aug; 91(4):324-34. PubMed ID: 20412339
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.
Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Alvarez AC; Rodriguez JC; Lamelas ML; Vizoso FJ
BMC Cancer; 2008 May; 8():149. PubMed ID: 18507821
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.
Zhang B; Cao X; Liu Y; Cao W; Zhang F; Zhang S; Li H; Ning L; Fu L; Niu Y; Niu R; Sun B; Hao X
BMC Cancer; 2008 Mar; 8():83. PubMed ID: 18373849
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.
Del Casar JM; González LO; Alvarez E; Junquera S; Marín L; González L; Bongera M; Vázquez J; Vizoso FJ
Breast Cancer Res Treat; 2009 Jul; 116(1):39-52. PubMed ID: 19241156
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas.
González LO; González-Reyes S; Marín L; González L; González JM; Lamelas ML; Merino AM; Rodríguez E; Pidal I; del Casar JM; Andicoechea A; Vizoso F
Histopathology; 2010 Dec; 57(6):862-76. PubMed ID: 21166700
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
17. Study of matrix metalloproteinases and their inhibitors in breast cancer.
Vizoso FJ; González LO; Corte MD; Rodríguez JC; Vázquez J; Lamelas ML; Junquera S; Merino AM; García-Muñiz JL
Br J Cancer; 2007 Mar; 96(6):903-11. PubMed ID: 17342087
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
19. MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival.
Nakopoulou L; Tsirmpa I; Alexandrou P; Louvrou A; Ampela C; Markaki S; Davaris PS
Breast Cancer Res Treat; 2003 Jan; 77(2):145-55. PubMed ID: 12602913
[TBL] [Abstract][Full Text] [Related]
20. Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer.
del Casar JM; Carreño G; González LO; Junquera S; González-Reyes S; González JM; Bongera M; Merino AM; Vizoso FJ
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1049-58. PubMed ID: 20041335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
